Ross Michael Jay
Insider CIK 1254452 · STRO Director, 10% owner · OPHT Director · CATB Director · ASNS Director, 10% owner · DCPH Director · XLO Director · TRXB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRXB TRex Bio, Inc. | A Award deriv | 2026-10-08 | 2026-10-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 13,200 | — | $0 | 13,200 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2021-10-21 | 2021-10-25 | 26,400 | — | $0 | 26,400 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-06-11 | 2019-06-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 141,249 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 194,786 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,155,794 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 6,683,697 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,217,015 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 52,183 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 106,019 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 17,533 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 5,462,550 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 11,097,596 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 1,835,270 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 64,815 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 131,683 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 21,776 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 193,492 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 251,783 | — | $0 | 863,503 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 270,690 | — | $0 | 611,720 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 341,030 | — | $0 | 341,030 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 1,931 | — | $0 | 8,817 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 6,128 | — | $0 | 6,886 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 758 | — | $0 | 758 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 202,115 | — | $0 | 923,022 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 641,440 | — | $0 | 720,907 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 79,467 | — | $0 | 79,467 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 2,399 | — | $0 | 10,952 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 7,610 | — | $0 | 8,553 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 7,207 | — | $0 | 7,207 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 5,721 | — | $0 | 12,928 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 5,320 | — | $0 | 18,248 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 943 | — | $0 | 943 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 4,978 | — | $0 | 52,183 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 4,978 | — | $0 | 4,315 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 521,159 | — | $0 | 5,462,550 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 521,159 | — | $0 | 451,869 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 6,183 | — | $0 | 64,815 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 6,183 | — | $0 | 5,361 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 26,033 | — | $0 | 26,033 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-06-07 | 2018-06-07 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2018-06-05 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-05-23 | 2018-07-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-05-17 | 2018-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 14,635 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 721,402 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 15,246 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 224,665 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 4,747 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 692,552 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 50,477 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 1,474,348 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 65,287 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 1,380 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 690,259 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 14,587 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 2,365 | — | $0 | 714,989 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 111,955 | — | $0 | 712,624 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 6,806 | — | $0 | 600,669 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 322,102 | — | $0 | 593,863 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 5,219 | — | $0 | 271,761 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 247,010 | — | $0 | 266,542 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 404 | — | $0 | 19,532 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 19,128 | — | $0 | 19,128 | SEC↗ |
| ASNS Arsanis, Inc. | P Buy | 2017-11-20 | 2017-11-20 | 16,552 | $10.00 | $165.5K | 1,868,961 | SEC↗ |
| ASNS Arsanis, Inc. | P Buy | 2017-11-20 | 2017-11-20 | 483,448 | $10.00 | $4.83M | 1,852,409 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 14,789 | — | $0 | 1,368,961 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 431,980 | — | $0 | 1,354,172 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 4,288 | — | $0 | 922,192 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 202,915 | — | $0 | 917,904 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2018-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2017-12-01 | 7,324 | — | $0 | 7,324 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-07-27 | 2017-07-28 | 6,500 | — | $0 | 6,500 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2017-05-19 | 2017-05-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2017-05-18 | 2017-05-22 | 1,750 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2017-05-18 | 2017-05-22 | 1,750 | — | $0 | 3,500 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-08-03 | 2016-08-05 | 6,500 | — | $0 | 6,500 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2016-06-02 | 2016-06-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2016-06-02 | 2016-06-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2016-06-01 | 2016-06-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2015-06-30 | 2015-06-30 | 11,094 | — | $0 | 11,094 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 1,750 | — | $0 | 1,750 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2014-05-21 | 2014-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2013-10-23 | 2013-10-25 | 22,033 | — | $0 | 22,033 | SEC↗ |